Moving times

Continuity and stability are vital when it comes to the EMA's relocation when it leaves London

16/10/2017

Following Brexit, Britain must pay to relocate the European Medicines Agency from London to a city within the EU and 19 European countries are placing their bids to be the next host. Indeed the EMA is favoured as being the most valuable of the Brexit spoils; its nature as one of the most prestigious European agencies bears both economic and political advantage for London's successor. Not only will it prove incredibly valuable for the victor of the fierce bidding war, its loss will be felt the British pharma industry.

Publicatie
PMLive_2017_10_16_a.pdf
Downloaden
PDF 147,9 kB

Auteurs

De foto van Willem Hoorneman
Willem Hoorneman
Managing Partner
Amsterdam
De foto van Ellen Gielen
Ellen Gielen
Partner
Utrecht